Proteomics International Laboratories Ltd
Research Proteomics International Laboratories Ltd (PIQ) on Bullrun: market cap AUD 27.29M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPIQ
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 27.29M
- Financial periodFY2025
- RevenueAUD 960.39K
- Revenue growth7.6%
- Net income-AUD 8.11M
- Free cash flow-AUD 6.63M
- Gross margin100.0%
Valuation Snapshot
latest market cap is AUD 27.29M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 960.39K | -AUD 8.11M | -AUD 6.63M | 100.0% | -0.06 | AUD 11.04M | AUD 277.74K | AUD 13.17M |
| FY2024 | AUD 892.14K | -AUD 6.38M | -AUD 6.00M | 100.0% | -0.05 | AUD 6.64M | AUD 316.40K | AUD 9.41M |
| FY2023 | AUD 730.34K | -AUD 6.18M | -AUD 6.91M | 100.0% | -0.05 | AUD 6.03M | AUD 64.09K | AUD 8.38M |
| FY2022 | AUD 1.49M | -AUD 4.97M | -AUD 3.67M | 100.0% | -0.05 | AUD 2.11M | n/a | AUD 3.39M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | AUD 27.29M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Proteomics International Laboratories Ltd
Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company's products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Proteomics International Laboratories Ltd's market cap?
Proteomics International Laboratories Ltd's market capitalization is AUD 27.29M.
What does Proteomics International Laboratories Ltd do?
Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD).